Industry growth factors include rising disposable income, burgeoning medical aesthetics market, and the influence of social media

Dublin, April 10, 2026 (GLOBE NEWSWIRE) — The “Scar Treatment Market: 2026 Edition” has been added to ResearchAndMarkets.com’s offering.

In 2024, the global scar treatment market was valued at US$29.45 billion and is forecasted to grow to US$52.12 billion by 2030. This growth is attributed to the increasing prevalence of skin conditions and injuries requiring scar management, alongside consumer interest in aesthetics and non-invasive options like creams and laser therapy.

Technological advancements in treatments, such as laser-based and regenerative medicine, are enhancing results, with combination therapies gaining popularity. The expanding medical aesthetics industry, rising disposable incomes, and enhanced access to dermatological services are also driving market growth. Online pharmacies, social media trends, and ongoing R&D in advanced scar interventions are further contributing to global market penetration, projected to grow at a CAGR of 9.98% during 2025-2030.

Market Segmentation Analysis

• By Scar Type: Segmented into atrophic, hypertrophic & keloid, contracture scars, and stretch marks, the atrophic scars division led the market in 2024, driven by common acne, chickenpox, and surgical scars. The stretch marks segment is anticipated to grow rapidly due to factors like increasing pregnancy and obesity rates, propelled by advanced treatment availability and skincare trends.
• By Treatment Type: The market is divided into topical products, laser therapies, injectables, and others. Topical products held the majority share in 2024, favored for their accessibility and cost-effectiveness. Laser therapies are predicted to be the fastest-growing segment, driven by technological advances and consumer willingness to invest in advanced skin solutions.
• By End-user: Categorized into hospitals & clinics, dermatology & aesthetic clinics, and retail & online pharmacies, the hospitals & clinics segment dominated due to their comprehensive care abilities. Dermatology & aesthetic clinics are forecasted to expand quickly, driven by the popularity of cosmetic procedures and technological advancements.
• By Region: North America led the scar treatment market in 2024, buoyed by skin disorder prevalence and substantial market player presence. The Asia Pacific market is set for rapid growth due to rising populations, increased disposable incomes, and evolving beauty standards.

Global Scar Treatment Market Dynamics:

• Growth Drivers: Rising disposable incomes and aesthetics spending, particularly in emerging markets, are key growth drivers. The enhanced focus on minimally invasive treatments, influenced by social media, promotes dermatological care demand. Additionally, increased healthcare expenditure and skin disorder incidences contribute to market expansion.
• Challenges: The high cost of advanced treatments like laser therapy and injectables restricts access, especially in developing regions, as they often are not insured. This economic barrier limits the adoption of cutting-edge scar treatments.
• Trends: There is a growing preference for minimally invasive procedures that offer efficacy with reduced discomfort. Innovations in laser systems and regenerative approaches enhance treatment options. Trends like AI adoption, energy-based devices, and biologics usage drive the market forward.

Competitive Landscape and Recent Developments

The moderately fragmented market features major players and regional entities. Key players like Smith & Nephew, Bausch Health, and Alliance Pharmaceuticals dominate. New strategies include Solta Medical’s Thermage® FLX certification in China, enhancing treatment offerings. The industry continues to evolve, focusing on new technologies and entering emerging markets to stay competitive.

Companies Featured in the Report:

• Smith & Nephew plc
• Bausch Health Companies Inc.
• Mölnlycke AB
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
• Sonoma Pharmaceuticals, Inc.
• Perrigo Company plc
• Alliance Pharma plc
• Merz Pharma GmbH & Co. KGaA
• Candela
• Cynosure
• CCA Industries, Inc.
• NewMedical Technology, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/k99p6p

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900